http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2503143-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d31351c76b18378e315027a536c70e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
filingDate | 1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f7a1f77ace0d2c496412b5458b36fb7 |
publicationDate | 1982-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | FR-2503143-A1 |
titleOfInvention | NOVEL PHENACYLAMINE DERIVATIVES, THEIR USE IN THERAPEUTICS AND THEIR PREPARATION METHOD |
abstract | THE PRESENT INVENTION RELATES AS NEW INDUSTRIAL PRODUCTS TO N- (2,4,6-TRIMETHOXYPHENACYL) -ALKYLAMINES OF THE FORMULA: (CF DRAWING IN BOPI) (OR R IS ISOPROPYL OR TERTIOBUTYL) AND THEIR ADDITIONAL SALTS. THESE NEW PRODUCTS ARE USEFUL THERAPEUTICALLY, ESPECIALLY AS SEDATIVE AND ANTIDEPRESSANT AGENTS OF THE CNS. THEY MAY BE PREPARED BY REACTION OF A 2,4,6-TRIMETHOXYPHENACYL HALOGENIDE WITH AN HNR AMINE. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2555576-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0143711-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0143711-A2 |
priorityDate | 1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.